Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $355.0000 (18.33%) ($355.0000 - $390.0000) on Wed. Feb. 25, 2009. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 13.73% (three month average) | RSI | 53 | Latest Price | $355.0000(18.33%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.3% a day on average for past five trading days. | Weekly Trend | CAPR declines -3.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IWM(3%) PEJ(3%) XOP(3%) EWI(2%) EWP(2%) | Factors Impacting CAPR price | CAPR will decline at least -6.865% in a week (0% probabilities). IGOV(-1%) EWY(-1%) XLU(0%) XLP(0%) VWO(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -6.865% (StdDev 13.73%) | Hourly BBV | 0 () | Intraday Trend | -9% | | | |
|
1 - 5 Day Possible Target | $331.54(-6.61%) | 5 Day Moving Average | $334(6.29%) | 10 Day Moving Average | $344.27(3.12%) | 20 Day Moving Average | $350.9(1.17%) | To recent high | -40.8% | To recent low | 69% | Market Cap | $6.993b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |